Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial Mechanism

ABSTRACT Choline kinase is the first enzyme in the Kennedy pathway (CDP-choline pathway) for the biosynthesis of the most essential phospholipid, phosphatidylcholine, in Plasmodium falciparum. In addition, choline kinase also plays a pivotal role in trapping essential polar head group choline inside the malaria parasite. Recently, Plasmodium falciparum choline kinase (PfCK) has been cloned, overexpressed, and purified. However, the function of this enzyme in parasite growth and survival has not been evaluated owing to the lack of a suitable inhibitor. Purified recombinant PfCK enabled us to identify an inhibitor of PfCK, hexadecyltrimethylammonium bromide (HDTAB), which has a very close structural resemblance to hexadecylphosphocholine (miltefosin), the well-known antiproliferative and antileishmanial drug. HDTAB inhibited PfCK in a dose-dependent manner and offered very potent antimalarial activity in vitro against Plasmodium falciparum. Moreover, HDTAB exhibited profound antimalarial activity in vivo against the rodent malaria parasite Plasmodium yoelii (N-67 strain). Interestingly, parasites at the trophozoite and schizont stages were found to be particularly sensitive to HDTAB. The stage-specific antimalarial effect of HDTAB correlated well with the expression pattern of PfCK in P. falciparum, which was observed by reverse transcription-PCR and immunofluorescence microscopy. Furthermore, the antimalarial activity of HDTAB paralleled the decrease in phosphatidylcholine content, which was found to correlate with the decreased phosphocholine generation. These results suggest that inhibition of choline kinase by HDTAB leads to decreased phosphocholine, which in turn causes a decrease in phosphatidylcholine biosynthesis, resulting in death of the parasite.

[1]  J. Rossier,et al.  Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes. , 1973, Molecular pharmacology.

[2]  S. Spanner,et al.  The inhibition of brain choline kinase by hernicholinium‐3 , 1974, Journal of Neurochemistry.

[3]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[4]  J. Haynes,et al.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.

[5]  C. Lambros,et al.  Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.

[6]  Efficient extraction and translation of Plasmodium falciparum messenger RNA. , 1982, Molecular and biochemical parasitology.

[7]  S. Kawamoto,et al.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. , 1984, Biochemistry.

[8]  J. Coyle,et al.  Characterization of [3H]hemicholinium-3 binding associated with neuronal choline uptake sites in rat brain membranes , 1985, Brain Research.

[9]  C. Warden,et al.  Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. , 1985, The Journal of biological chemistry.

[10]  H. Vial,et al.  Inhibitors of choline transport into Plasmodium-infected erythrocytes are effective antiplasmodial compounds in vitro. , 1985, Biochemical pharmacology.

[11]  H. Vial,et al.  Several lines of evidence demonstrating that Plasmodium falciparum, a parasitic organism, has distinct enzymes for the phosphorylation of choline and ethanolamine , 1986, FEBS letters.

[12]  H. Vial,et al.  Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport , 1986, Antimicrobial Agents and Chemotherapy.

[13]  H. Vial,et al.  Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes. , 1989, Biochimica et biophysica acta.

[14]  S. Cook,et al.  Analysis of the water-soluble products of phosphatidylcholine breakdown by ion-exchange chromatography. Bombesin and TPA (12-O-tetradecanoylphorbol 13-acetate) stimulate choline generation in Swiss 3T3 cells by a common mechanism. , 1989, The Biochemical journal.

[15]  D. Warhurst.  Chemotherapy and drug resistance in malaria (2nd edn): by W Peters, Academic Press, 1987. £63.00 (Vol. 1) £75.00 (Vol. 2) (1100 pages) ISBN 0 12 552721 7 , 1989 .

[16]  M. Hagiwara,et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.

[17]  A. Cuadrado,et al.  Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. , 1993, Oncogene.

[18]  T. Wieder,et al.  N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulphonamide (H-89) inhibits incorporation of choline into phosphatidylcholine via inhibition of choline kinase and has no effect on the phosphorylation of CTP:phosphocholine cytidylyltransferase. , 1994, The Biochemical journal.

[19]  J. Lacal,et al.  Choline kinase inhibitors as a novel approach for antiproliferative drug design , 1997, Oncogene.

[20]  Increased synthesis of phosphocholine is required for UV-induced AP-1 activation , 1998, Oncogene.

[21]  Irwin W. Sherman,et al.  Malaria : parasite biology, pathogenesis, and protection , 1998 .

[22]  D. Berkovic,et al.  Cytotoxic etherphospholipid analogues. , 1998, General pharmacology.

[23]  Z. Kiss,et al.  The choline kinase inhibitor hemicholinium-3 can inhibit mitogen-induced DNA synthesis independent of its effect on phosphocholine formation. , 1998, Archives of biochemistry and biophysics.

[24]  H. Vial,et al.  Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. , 1998, Blood.

[25]  J. Lacal,et al.  In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery. , 1999, Cancer research.

[26]  R. Price.  Artemisinin drugs: novel antimalarial agents , 2000, Expert opinion on investigational drugs.

[27]  A. Stead,et al.  Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. , 2001, Molecular pharmacology.

[28]  Christian Hott,et al.  Co‐ordinated programme of gene expression during asexual intraerythrocytic development of the human malaria parasite Plasmodium falciparum revealed by microarray analysis , 2001, Molecular microbiology.

[29]  G. Carman,et al.  Phosphorylation of Saccharomyces cerevisiae Choline Kinase on Ser30 and Ser85 by Protein Kinase A Regulates Phosphatidylcholine Synthesis by the CDP-choline Pathway* , 2002, The Journal of Biological Chemistry.

[30]  M. P. Carrasco,et al.  Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells. , 2002, European journal of biochemistry.

[31]  H. Vial,et al.  A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes , 2002, Science.

[32]  J. Lacal,et al.  Regulation of choline kinase activity by Ras proteins involves Ral–GDS and PI3K , 2002, Oncogene.

[33]  Sang-Seop Han,et al.  Choline phosphate potentiates sphingosine-1-phosphate-induced Raf-1 kinase activation dependent of Ras--phosphatidylinositol-3-kinase pathway. , 2002, Cellular signalling.

[34]  H. Vial,et al.  Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial Activities , 2003, Antimicrobial Agents and Chemotherapy.

[35]  H. Vial,et al.  Heme Binding Contributes to Antimalarial Activity of Bis-Quaternary Ammoniums , 2003, Antimicrobial Agents and Chemotherapy.

[36]  H. Vial,et al.  In Vivo Antimalarial Activities of Mono- and Bis Quaternary Ammonium Salts Interfering with Plasmodium Phospholipid Metabolism , 2003, Antimicrobial Agents and Chemotherapy.

[37]  Ruth H. Hughes,et al.  Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. , 2004, Blood.

[38]  Choukri Ben Mamoun,et al.  Unraveling the Mode of Action of the Antimalarial Choline Analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae , 2004, Antimicrobial Agents and Chemotherapy.

[39]  K. Kirk,et al.  Choline uptake into the malaria parasite is energized by the membrane potential. , 2004, Biochemical and Biophysical Research Communications - BBRC.

[40]  G. Pessi,et al.  A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Berman,et al.  Advances in leishmaniasis , 2005, The Lancet.

[42]  G. Pessi,et al.  In Vivo Evidence for the Specificity of Plasmodium falciparum Phosphoethanolamine Methyltransferase and Its Coupling to the Kennedy Pathway* , 2005, Journal of Biological Chemistry.

[43]  G. Carman,et al.  Phosphorylation of the Yeast Choline Kinase by Protein Kinase C , 2005, Journal of Biological Chemistry.

[44]  J. Berman.  Clinical status of agents being developed for leishmaniasis , 2005, Expert opinion on investigational drugs.

[45]  V. Choubey,et al.  Molecular characterization and localization of Plasmodium falciparum choline kinase. , 2006, Biochimica et biophysica acta.